SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-014169
Filing Date
2010-03-17
Accepted
2010-03-17 17:11:08
Documents
9
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 v177246_10k.htm 10-K 1420412
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC spacer.gif GRAPHIC 43
4 v177246_ex10-16.htm EX-10.16 19024
5 v177246_ex23-1.htm EX-23.1 4148
6 v177246_ex31-1.htm EX-31.1 17184
7 v177246_ex31-2.htm EX-31.2 17517
8 v177246_ex32-1.htm EX-32.1 7845
9 v177246_ex32-2.htm EX-33.2 8216
  Complete submission text file 0001144204-10-014169.txt   1496284
Mailing Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036
Business Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036 646-214-0700
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33038 | Film No.: 10689452
SIC: 8093 Services-Specialty Outpatient Facilities, NEC